Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results
PaperCitations, authors & open-access status
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 592 citations, 2023 year and hybrid oa status.
592
Citations
2023
Year
hybrid
OA Status